Characterizing preclinical models of ischemic heart failure: differences between LAD and LCx infarctions
Year: 2014
Type: article
Abstract: Large animal studies are an important step toward clinical translation of novel therapeutic approaches. We aimed to establish an ischemic heart failure (HF) model with a larger myocardial infarction (MI) relative to previous studies, and characterize the functional and structural features of this model. An MI was induced by occluding the proximal left anterior descending artery (LAD; n = 15) or the proximal left circumflex artery (LCx; n = 6) in Yorkshire pigs. Three pigs with sham procedures were also included. All pigs underwent hemodynamic and echocardiographic assessments before MI, at 1 mo, and 3 mo after MI. Analyses of left ventricular (LV) myocardial mechanics by means of strains and torsion were performed using speckle-tracking echocardiography and compared between the groups. The proximal LAD MI approach induced larger infarct sizes (14.2 ± 3.2% vs. 10.6 ± 1.9%, P = 0.03), depressed systolic function (LV ejection fraction; 39.8 ± 7.5% vs. 54.1 ± 4.6%, P < 0.001), and more LV remodeling (end-systolic volume index; 82 ± 25 ml/m(2) vs. 51 ± 18 ml/m(2), P = 0.02, LAD vs. LCx, respectively) compared with the LCx MI approach without compromising the survival rate. At the papillary muscle level, echocardiographic strain analysis revealed no differences in radial and circumferential strain between LAD and LCx MIs. However, in contrast with the LCx MI, the LAD MI resulted in significantly decreased longitudinal strain. The proximal LAD MI model induces more LV remodeling and depressed LV function relative to the LCx MI model. Location of MI significantly impacts the severity of HF, thus careful consideration is required when choosing an MI model for preclinical HF studies.
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: C-TRIP: Targeted Gene Therapy for the Treatment of Heart Failure (P20), K and Ca Channels in Cardiac Hypertrophy and Failure, Targeting Abnormal Calcium Cycling Using Novel Gene Therapy Vectors, G378321137, G4393796485, PICOT and Cardiac Hypertrophy, G618359847, G6632036768, Regression of cardiac hypertrophy, Targeting Calcium Cycling in a Pre-Clinical Model of Cardiac Dysfunction, G755177338, Improving Mitral Compensation in Ischemic Regurgitation, Treating Ventricle and Valve: New Synergies for Ischemic LV Remodeling with MR, Gene Therapy with Cardiotropic Vectors for the Treatment of Heart Failure
OpenAlex ID: W2143687214
